Full name
REMES 1 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,1 | 0 | 0 | 41 |
EBITDA | -0,1 | 0,1 | 0,1 | 24,2 |
Short time liabilities | 0,8 | 1,1 | 1,1 | -3,5 |
Equity capital | -0,5 | -0,5 | -0,4 | 7,4 |
Operating profit (EBIT) | -0,1 | 0,1 | 0,1 | 28,3 |
Assets | 0,3 | 0,6 | 0,6 | -0,6 |
Net profit (loss) | -0,1 | 0 | 0 | 41 |
Cash | 0 | 0,1 | 0,1 | 15 |
Net income from sale | 2,5 | 2,9 | 3,1 | 8,4 |
Liabilities and provisions for liabilities | 0,8 | 1,1 | 1,1 | -3,5 |
Working assets | 0,3 | 0,6 | 0,6 | -0,5 |
Depreciation | 0 | 0 | 0 | -66,9 |
% | % | % | p.p. | |
Profitability of capital | 24,9 | -5,2 | -8 | -2,8 |
Equity capital to total assets | -139,4 | -72,6 | -67,6 | 5 |
Gross profit margin | -4,9 | 0,8 | 1,1 | 0,3 |
EBITDA Margin | -4,2 | 2 | 2,3 | 0,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 124 | 138 | 123 | -15 |
Current financial liquidity indicator | 0.41324517130851746 | 0.5783696174621582 | 0.5962770581245422 | 0 |
Net dept to EBITDA | -3.2637784481048584 | 6.754385471343994 | 4.813744068145752 | -2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane